Antibiotic policies in developing countries

Antibiotic Policies: Theory and Practice

Volumn , Issue , 2005, Pages 593-616

  Sosa, Aníbal ^a  

^a Alliance for the Prudent Use of Antibiotics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951189327     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-22852-7_31     Document Type: Chapter

References (61)

1. Asturias, E., Dueger, E., Torres, O., Grazioso, C, and Figueroa, J., 2003, Risk Factors for Antibiotic Resistance of Streptococcus pneumoniae Among Guatemalan Children from Different Socio-economic Strata and Health Care Delivery Systems: Preliminary Surveillance for a Program for the Judicious Use of Antibiotics in the Outpatient Setting. National Congress of Pediatrics, Guatemala City, Guatemala.
2. Bartoloni, A., Cutts, F., Leoni, S., Austin, C, Mantella, A., and Guglielmetti, P., 1998, Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. Trop. Med. Int. Health, 3, 116-123.
3. Bavestrello, L. and Cabello, A., 2000, How Chile tackled overuse of antimicrobials. WHO Essential Drugs Monitor, Issue No 28-29, 13-14.
4. Becker, J., Drucker, E., Enyong, P., and Marx, P., 2002, Availability of injectable antibiotics in a town market in southwest Cameroon. Lancet Infect. Dis., 2, 325-326.
5. Beilby, J., Marley, J., Walker, D., Chamberlain, N, Burke, M., and Group, F. S., 2002, Effect of changes in antibiotic prescribing on patient outcomes in a community setting: A natural experiment in Australia. Clin. Infect. Dis., 34, 55-64.
6. Bojalil, R., and Calva, J., 1994, Antibiotic misuse in diarrhea. A household survey in a Mexican community. J. Clin. Epidemiol, 47(2), 147-156.
7. Brock, D., 2001, Some questions about the moral responsibilities of drug companies. Dev World Bioethics, 1, 33-37.
8. Calva, J., 1996, Antibiotic use in a periurban community in Mexico: a household and drugstore survey. Soc. Sci. Med., 42(8), 1121-1128.
9. CDC 2002, Summary Report of a Public Health Meeting: Input for a Public Health Action Plan to Combat Anitmicrobial Resistance. Part II: Global Issues, The U.S. Federal Interagency Task Force on Antimicrobial Resistance.
10. Cunha, B., 2003, Penicillin resistance in pneumococcal pneumonia. Postgrad. Med., 113(1) 42-44, 47-48.
11. ESCMID, 2002, Study Group on Antibiotic policies, European Society of Clinical Microbiology and Infectious Diseases.
12. Fidler, D P., 1998, Legal Issues Associated with Antimicrobial Drug Resistance. Emerging Infect. Dis., 4(2).
13. Gamboa, L., Camou, T, Hortal, M., and Castaneda, E., 2002, Dissemination of Streptococcus pneumoniae Clone Colombia5-19 in Latin America. J. Clin. Microbiol., 40(11), 3942-3950.
14. Geue, A., 2000, Containing antibiotic resistance: Australia's contribution to the global strategy. Communicable Diseases Intelligence 24(10).
15. Gonzales, R., Steiner, J., Lum, A., and Barrett, P., 1999, Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. J. Am. Med. Assoc, 281(16), 1512-1519.
16. Gordon, D, Noah, D, Fidas, G, and Gannon, J., 2000, The Global Infectious Disease Threat and Its Implications for the United States. Central Intelligent Agency, Washington, DC.
17. Gould I. M., 2002, Antibiotic policies and control of resistance. Curr. Opinion Infect. Dis., 15, 395-400.
18. Gundersen, S., 1992, Resistance problems in developing countries-use and misuse of anti-infective agents. Tidsskr Nor Laegeforen, 112(21), 2741-2746.
19. Harrison, P. and Lederberg, J., 1998, Antimicrobial Resistance: Issues and Options. Workshop Report. Institute of Medicine, National Academy of Sciences, Washington p. 115.
20. Hemming, M., and Harvey, K., 1999, International Strategies on Antibiotics, Health Action International News.
21. Holloway, K., and Gautam, B., 2001, Consequences of over-prescribing on the dispensing process in rural Nepal. Trop. Med. Int. Health, 6(2), 151-154.
22. Jeena, P., Thompson, E., Nchabeleng, M., and Sturm, A., 2001, Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: Concern about antimicrobial policies. Ann Trop Paediatr. 21(3), 245-251.
23. Kollef, M., (2001). Antibiotic Resistance Among Gram-Positive Bacteria in the Hospital Setting: What Can We Do About It? Medscape Infectious Diseases.
24. McCaig, L., Besser, R., and Hughes, J., 2003, Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg. Infect. Dis., 9(4), 432-437.
25. McCaig, L. F. and Hughes, J. M., 1995, Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 273(3), 214-219.
26. McGowan, J. E. (2001). Economic impact of antimicrobial resistance. Emerg. Infect. Dis., 7(2).
27. McManus, P., Hammond M., Whicker, S., Primrose, J., Mant, A., and Fairall, S., 1997, Antibiotic use in the Australian community, 1990-1995. MJA, 167(3), 124-127.
28. Nathwani, D. and Davey, P., 1999, Antibiotic-prescribing-are there lessons for physicians? Q. J. Med., 92(5), 287-292.
29. O'Dempsey, T, McArdle, T, Lloyd-Evans, N, Baldeh, I., Lawrence, B., Secka, O., and Greenwood, B., 1996, Pneumococcal disease among children in a rural area of west Africa. Pediatr. Infect. Dis. J., 15(5), 431-437.
30. Odhacha, A., 1998, Health worker performance after training in integrated management of childhood illness-Western province, Kenya, 1996-1997. MMWR, 47(46), 998-1001.
31. Okeke, I., Lamikanra, A., and Edelman, R., 1999, Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg. Infect. Dis. 5(1).
32. Okeke, I., and Sosa, A., 2003, Antibiotic resistance in africa-discerning the enemy and plotting a defense. Africa Health 25(3), 10-15.
33. Paredes, P., 1996, Factors influencing physicians' prescribing behaviour in the treatment of childhood diarrhoea: Knowledge may not be the clue. Soc. Sci. Med., 42(8), 1141-1153.
34. Prazuck, T., Falconi, I., Morineau, G, Bricard-Pacaud, V, Lecomte, A., and Ballereau, F, 2002, Quality control of antibiotics before the implementation of an STD program in Northern Myanmar. Sex Transm. Dis. 29(11), 624-627.
35. Riewpaiboon, A., Sunderland V., Passmore, P., Sirinavin, S., Jirasmitha, S., Tangcharoensathien, V. et al., 1997, Evaluation of cost and appropriateness of antibiotic prescribing for community-acquired pneumonia using a novel computer program. In State of the Art and Future Directions. Chiang Mai, Thailand and School of Pharmacy, Curtin University of Technology, Western Australia.
36. Rodriguez, A. J., Samaniego, D. R, Soskin, A., Rodriguez, C, Canese, J., de Canese, J., et al., 2002, Comparative study of antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of Caracas and Asuncion in a 4-year-period. Chemotherapy 48(4), 164-167.
37. Salvatierra-Gonzalez, R., and Benguigui, Y., (eds.), 2000, Resistencia Antimicrobiana en la Americas: Magnitud del problema y su contencion. Washington, DC, OPS/HCP/HCT/163/2000.
38. Schüklenk, U. and Ashcroft, R., 2001, Affordable access to essential medication in developing countries: Conflicts between ethical and economic imperatives. J. Med. Philos., 27(2), 179-195.
39. Scrip (2003). USTR Looks at Counterfeits and Data Exclusivity. PJB Publications Ltd, Surrey. p. 18.
40. Sintchenko, V, Iredell, J., Gilbert, G., and Coiera, E., 2001, What do physicians think about evidence-based antibiotic use in critical care? A survey of Australian intensivists and infectious disease practitioner. Int. Med. J. 31, 462-469.
41. Sosa, A. and Stelling, J., 2003, Using AMR Surveillance Data to Select Antimicrobial Agents for the Treatment of Key Bacterial Infectious Diseases in Nepal. The Alliance for the Prudent Use of Antibiotics (APUA), Boston, MA.
42. Sosa, A. and Travers, K., 2001, PAHO/APUA Report on Physician Antibiotic Prescribing Practices And Knowledge in Seven Countries in Latin America. The Alliance for the Prudent Use of Antibiotics (APUA), Boston, MA.
43. South, M., Royle, J., and Starr, M., 2003, A simple intervention to improve hospital antibiotic prescribing. Med. J. Aust. 178, 207-209.
44. Steinman, M., Gonzales, R., Linder, J., and Landefeld, C., 2003, Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann. Intern. Med. 138(7), 525-533.
45. Sterling, T. R., Lehmann, H. P., and Frieden, T. R, 2003, Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: Decision analysis. BMJ326(7389), 574.
46. Stratchounski, L., Andreeva, I., Ratchina, S., Galkin, D., Petrotchenkova, N, Demin, A. et al., 2002, The Inventory of Antibiotics in Home Medicine Cabinets-The Results of Russian Nation-wide Cross-sectional Observational Study, 42nd ICAAC Abstracts, American Society for Microbiology, San Diego, CA.
47. Sudha, V, Prasad, A., Soni, G, Khare, S., and Singh, S., 2003, Simple Criteria for Choosing Antimicrobials for Empiric Therapy of Typhoid Based on Existing Susceptibility Patterns of S. typhi Strains-a Model Proposed. 4th International Symposium on Antimicrobial Agents and Resistance (ISAAR 2003), Seoul, Korea.
48. Tapsall, J., 2001, Antimicrobial Resistance-Susceptibility Surveillance Linked to Public Health Action. Presentation at the Antibiotic Resistance Surveillance Workshop. Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR). Melbourne, Australia.
49. Tawfik, Y., 2000, Promising interventions for improving private practitioner's practices in child survival. Global Health Link: The Newsletter of the Global Health Council 105, 19-20.
50. TRIPS, 2001, Declaration on the TRIPS Agreement and Public Health. The Fourth WTO Ministerial Conference, Doha, Qatar, World Trade Organization.
51. Tufts-CSDD, 2001, Tufts Center for the Study of Drug Development Pegs Cost of a New Prescription Medicine at $802 Million.
52. Tufts-CSDD, 2003, Total Cost to Develop a New Prescription Drug, Including Cost of Post-Approval Research, is $897 Million. Unknown, 2001, The Microbial Threat. Visby Conference 2001. Visby, EU2001.SE.
53. Unknown, 2002, Illegal prescription drug distribution is big business. Infect. Dis. News.
54. Wachter, D., Joshi, M., and Rimal, B., 1999, Antibiotic dispensing by drug retailers in Kathmandu, Nepal. Trop. Med. Int. Health 4(11), 782-788.
55. WHO, 1996a, ATC Classification Index. Geneva, WHO Collaborating Centre for Drug Statistics Methodology.
56. WHO, 1996b, Guidelines for Drug Donations. Geneva World Health Organization.
57. WHO, 1999, Removing Obstacles to Healthy Development. Geneva.
58. WHO, 2000, Overcoming Microbial Resistance. Infectious Disease Report. Geneva, World Health Organization-http://www.who.int/infectious-disease-report/ 2000/htm.
59. WHO, 2001, The Multi-Country Evaluation of IMCI Effectiveness, Cost and Impact (MCE). Department of Child and Adolescent Health and Development. Geneva.
60. WHO, 2002, The medicines Crossing Borders Project-improving the quality of donations." Essential Drugs Monitor 31, 35.
61. Wilton, P., Smith, R., Coast, J., and Millar, M., 2002, Strategies to contain the emergence of antimicrobial resistance: A systematic review of effectiveness and cost-effectiveness. J. Health Serv. Res. Policy, 7(2), 111-117.